Welcome to BioArctic’s website. In order to optimize your use of our website we use cookies. If you want more information about our cookie policy, please read more here. By continuing, you agree to our use of cookies.

Close

logo

Loading..
Svenska
  • Home
  • About us
    About us
      • About BioArctic
      • CEO Gunilla Osswald presents BioArctic
      • Vision and mission
      • Culture and values
      • Objective and strategy
      • Collaborations and partners
      • Sustainability
        • Code of Conduct
        • Work environment
        • Diversity
      • Organization
        • Board of directors
        • Senior management
        • Scientific advisory boards
      • History
  • Research and development
    Research and development
      • Technology
      • Pipeline
      • Therapeutic Areas
        • Neurodegenerative disorders
        • Alzheimer´s disease
        • Parkinson’s disease
      • Therapeutic Areas
        • Complete Spinal Cord Injury
        • Other diseases
  • Governance
    Governance
      • Governance structure
      • Corporate Governance Reports
      • General Meeting
        • General Meetings
      • Nomination Committee
        • Nomination Committees
      • Board of Directors
        • Board Committees
        • Work of the Board of Directors
      • Senior management
      • Remuneration
      • Internal audit and control
      • Audit
      • Articles of Association
  • Investors
    Investors
      • The share
        • Share capital development
        • Dividend
        • Ownership structure
        • Analysts
      • Financial reports
      • Prospectus
      • Presentations
      • Press releases
      • News
      • Calendar
      • Privacy policy - Shareholders
      • Subscribe
      • Contact
  • Media
    Media
      • Press releases
      • News
      • Image bank
      • Subscribe
      • Contacts
  • Career
  • Contacts
    Contacts
      • Office
      • Investors
      • Media
Svenska
June 10, 2019

Redeye Growth Day Presentation and Interview with EFN

Gunilla Osswald, CEO, presented BioArctic at the Redeye Growth Day in Stockholm, Sweden.

Video (in Swedish)

EFN Interview (in Swedish)

https://www.efn.se/bors-finans/biorctic-ser-framgangar-inom-samtliga-omraden/

Calendar

  • October 24, 2019Interim Report January – September 2019
  • December 4, 2019 - December 7, 2019International Conference on Clinical Trials for Alzheimer’s Disease (CTAD)
  • February 6, 2020Full Year Report 2019
More events

Subscribe

Read more about how we protect your personal data.
  • Investors
    • The share
      • Share capital development
      • Dividend
      • Ownership structure
      • Analysts
    • Financial reports
    • Prospectus
    • Presentations
    • Press releases
    • News
    • Calendar
    • Privacy policy – Shareholders
    • Subscribe
    • Contact
Jan Mattsson
Jan Mattsson
Vice President Finance, Chief Financial Officer
jan.mattsson@bioarctic.se
+46 703 52 27 72
About us
  • About BioArctic
  • CEO Gunilla Osswald presents BioArctic
  • Vision and mission
  • Culture and values
  • Objective and strategy
  • Collaborations and partners
  • Sustainability
  • Organization
  • History
Research and development
  • Technology
  • Pipeline
  • Therapeutic Areas
Governance
  • Governance structure
  • Corporate Governance Reports
  • General Meeting
  • Nomination Committee
  • Board of Directors
  • Senior management
  • Remuneration
  • Internal audit and control
  • Audit
  • Articles of Association
Investors
  • The share
  • Financial reports
  • Prospectus
  • Presentations
  • Press releases
  • News
  • Calendar
  • Privacy policy – Shareholders
  • Subscribe
  • Contact
Media
  • Press releases
  • News
  • Image bank
  • Subscribe
  • Contacts
Career
  • Career
Contacts
  • Office
  • Investors
  • Media

BioArctic AB, Warfvinges väg 35, SE-112 51 Stockholm, Sweden. Phone: +46 8 695 69 30. E-mail: info@bioarctic.se. Registration number: 556601-2679.

© 2019 BioArctic AB – All rights reserved

  • About Cookies
  • Processing of personal data